Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.
Saved in:
| Title: | Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity. |
|---|---|
| Authors: | Isnard S; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Mabanga T; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Royston L; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Berini CA; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Bu S; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Aiyana O; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Feng H; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Lebouché B; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.; Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Costiniuk CT; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Cox J; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Kroemer G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, assistance publique des hôpitaux de Paris (AP-HP), Paris, France., Durand M; Département de Microbiologie, Infectiologie et Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Routy JP; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Hematology, McGill University Health Centre, Montreal, QC, Canada. |
| Corporate Authors: | Biobanque Québécoise de la COVID-19 (BQC-19) |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jan 06; Vol. 15, pp. 1505752. Date of Electronic Publication: 2025 Jan 06 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1505752 |
